In 2017, the Evidence-Based Practice Group conducted reviews on naltrexone as treatment for complex regional pain syndrome (CRPS) (June 2017), and neuropathic pain (September 2017). This 2019 review aims to determine whether there is new evidence to support the efficacy and/or effectiveness of naltrexone as treatment for neuropathic pain or complex regional pain syndrome (CRPS).